Catalyst Wire Dossier Catalyst Wire Dossier

tapentadol extended-release tablet

tapentadol · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for tapentadol extended-release tablet, covering 2013-12-24 to 2013-12-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Bioequivalence of a New Tapentadol Extended-Release Tablet With Respect to a Tapentadol Extended Release Tablet Under Fasted Conditions in Healthy Subjects [Phase 1]

See pricing